First Round of Late-Breaking Clinical Trial Results Announced at VIVA23

/PRNewswire/ -- The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and...

Related Keywords

Switzerland ,Japan ,United States ,Germany ,New Zealand ,Japanese ,Thomas Zeller ,Daniel Clair ,Anvar Babaev ,Osamu Iida ,Gore Viabahn ,Mahmood Razavi ,Wynn Las Vegas ,Gore Associates ,Medtronic ,Vibrato Inc ,Limflow Inc ,Late Breaking Clinical Trial ,Wynn Las ,Vascular Interventional Advances ,Month Results From ,Non Invasive Therapeutic Ultrasound ,Increase Perfusion ,Chronic Limb Threatening Ischemia ,Vascular Quality ,Walking Impairment Questionnaire ,Year Results ,Bare Temporary Spur Stent System ,Combination With ,Bare Temporary Spur ,Reflow Medical ,Versus Orbital Atherectomy ,Femoropopliteal Artery Lesions ,Restenosis Rates ,Year Outcomes ,Complex Femoropopliteal Lesions ,The Viva Foundation ,